Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...
Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...
Divis Laboratories is reporting earnings from the most recent quarter on August 8. Wall Street analysts predict earnings per share of INR 11.98. Follow Divis Laboratories stock price in real-time here ...
Divis Laboratories shares declined by 2.05% to Rs 6,061.00 in Thursday's session. At 11:48 am, the stock was trading lower compared to its previous close. The company's consolidated financial ...
Divi's Laboratories Ltd (NSE:DIVISLAB) is set to release its Q2 2026 earnings on Nov 7, 2025. The consensus estimate for Q2 2026 revenue is $25.86 billion, and the earnings are expected to come in at ...
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025. - Rediff MoneyWiz, the personal finance ...
Divis Laboratories Ltd is quoting at Rs 6125.5, down 1.77% on the day as on 13:19 IST on the NSE. The stock jumped 2.08% in last one year as compared to a 9.4% rally in NIFTY and a 0.15% fall in the ...
Murali Krishna Divi Chairman and managing director, Divis Laboratories Age: 63 Rank in the Rich List: 45 Net Worth: $2.03 billion The Big Challenge Faced in the Last Year: Managing growth in an ...
Earnings call Divi's Laboratories reported a 17% YoY revenue growth in Q2 FY26, driven by a record 56% contribution from custom synthesis. Margins remained resilient despite ongoing generic pricing ...
Trade Brains on MSN
Is 2026 a turning point for Divis Laboratories? Here's what Citi says about the pharma stock
India, Jan. 15 -- The shares of this pharma stock, engaged in the manufacturing and exporting of API's and Nutraceutical ingredients, are in focus after leading global brokerage, CITI, has expressed ...
Divi’s Laboratories (DIVI) Q2FY26 EBITDA was a beat; 7% above our estimates led by higher CS revenues. We expect margins to improve, led by better product mix and stable raw material prices. Mgmt.
On June 6, Divis Laboratories releases figures for Q4. Wall Street analysts expect Divis Laboratories will be reporting earnings per share of INR 14.95. Follow Divis Laboratories stock price in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results